Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 7Prostatic Neoplasms 4Precancerous Conditions 2Neoplasms 2Weight Loss 1Uterine Cervical Neoplasms 1Radiation Injuries 1Psoriasis 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Pelvic Inflammatory Disease 1Pain 1Ovarian Neoplasms 1Osteoarthritis 1Fatigue 1Esophageal Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthralgia 1

Interventions

Surveys and Questionnaires 2Exercise 2Acupuncture Therapy 2methyl hydroxyethyl cellulose 1guizhi-shaoyao-zhimu decoction 1Yoga 1Walking 1Vitamin B 12 1Occupational Therapy 1Fatty Acids, Omega-3 1Educational Status 1Docosahexaenoic Acids 1Diet Therapy 1Curcumin 1Acupressure 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Arthralgia × Fatty Acids, Omega-3 × Clear all
NCT02831582 2023-02-27

Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
75 enrolled
Breast

Breast Neoplasms, Arthralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡